
Alberta babies have been born with measles due to outbreaks, worrying doctors
Social Sharing
As the province's measles case count approaches 1,000, health experts are raising the alarm about Alberta babies who are being born already infected with the virus.
The provincial government has confirmed cases of congenital measles, which can lead to severe complications, including death, have already occurred as a result of this year's outbreaks. Pregnant Albertans are also testing positive.
"Fewer than five cases of congenital measles have been reported in Alberta in 2025. In each case, the mother was not immunized. Information on whether the infants were born prematurely is not available," an official with Primary and Preventative Health Services said in an email.
"To date, there have been 20 confirmed cases of measles in pregnant individuals. Fewer than five have been hospitalized due to the infection."
The Alberta government does not publish this information publicly. CBC News asked for the data after Ontario reported a premature baby, born infected with measles, died. That province has reported seven cases of congenital measles since mid-October.
When CBC News asked for more detailed data, an official said the province limits the release of information when case numbers are very small for privacy reasons. The data was up-to-date as of June 12.
No measles deaths have been reported in Alberta since the outbreaks began this year.
As of June 14, a total of 85 Albertans had been hospitalized due to the infection, including 14 intensive care unit admissions.
By midday Thursday, the province's total measles case count had climbed to 996.
Serious complications
Pregnant individuals are at higher risk of complications from measles.
"We're extremely concerned about the potential for exposures for unimmunized mothers, in particular during pregnancy, given that there is an increased risk for premature birth and complications that are pretty significant for the mother," said Dr. Amber Reichert, an Edmonton-based neonatologist.
"There is an extremely high risk to either pregnancy loss or potentially an early birth or potentially the babies becoming infected as well."
A recent editorial in the Canadian Medical Association Journal warned of these serious consequences.
Premature birth itself comes with risks, including underdeveloped lungs and babies requiring breathing support.
In addition, pregnant people can get very sick from a measles infection, often due to pneumonia.
"There is a ten-fold higher risk of death when a person who is pregnant gets measles," said Dr. Eliana Castillo, an obstetrician and clinical associate professor in the department of medicine at the University of Calgary.
What is congenital measles
Congenital measles occurs when the mother passes the infection along in the final two weeks of pregnancy and the baby is born infected, according to Castillo.
It can spark severe complications in the infant, including brain inflammation and even death, according to the U.S. Centers for Disease Control and Prevention.
"Those babies can be very, very sick," said Castillo.
Ontario announced earlier this month that a premature baby born with congenital measles had died. The infant's mother was unimmunized. At the time, health officials said measles was a "significant contributing factor" to the premature death but that the baby also had other serious health problems.
In addition to a fever and rash, babies with congenital measles can be born with other symptoms, including inflammation of the liver, physicians are warning.
"They potentially could also present with pneumonia or potentially have an infection around the brain, which is called encephalitis," said Reichert.
If the baby is born early — and has congenital measles — there is a higher risk of serious lung disease due to the immaturity of their lungs, she added.
And beyond the immediate health concerns, there are several potential and serious long-term consequences, including a rare but debilitating neurological illness that manifests years later.
Subacute sclerosing panencephalitis is a virus that hides in the brain for years. It eventually flares up, triggering brain inflammation and causing children or young adults to lose the ability to move and speak. In nearly all cases patients die.
According to Reichert, the risk of this complication is believed to be higher when a baby is born with measles or is infected early in infancy.
"It's a devastating consequence because it really isn't treatable," said Reichert.
Babies can also experience immune system impacts that leave them more highly susceptible to illness, Castillo said.
A major worry
Measles is highly contagious and health officials have warned that given low immunization rates in parts of the province, official case counts are the tip of the iceberg and there are likely more cases going unreported.
It's a major worry for physicians.
"Everyone is concerned this is going to be happening for months at a time," Castillo said, adding that as case counts rise, so too do the chances that more babies will be infected and potentially face life-altering or life-threatening complications.
She's concerned that Albertans don't fully understand the risks that go along with pregnancy and measles.
"We have not had a concerted public health response, particularly to raise awareness about how serious it can be for babies and pregnant individuals," she said, adding she's glad the province shared the data it did when requested by CBC News.
"But again they're not in the public domain. And that makes it very, very hard because we haven't had the concerted effort to raise awareness … and give people the tools to make decisions."
CBC News asked the province if it will publish this information moving forward, but did not hear back prior to publication time.
Reichert wants Albertans to understand the risks and she's urging everyone to ensure that they and their children are immunized to protect both themselves and others around them who may not be able to be immunized.
Mothers who are immunized pass antibodies on to the fetus during pregnancy, offering protection during a baby's first few months of life.
Post-exposure therapy
The measles vaccine (MMR) is not generally recommended during pregnancy in Canada.
Pregnant Albertans who are unimmunized and have been exposed to measles and infants under six months of age are among the high risk groups who may be offered immune globulin, a short-acting antibody medication that can protect against the virus.
It must be given within six days of exposure.
According to the province, 52 people have received it including 37 infants since the outbreaks began in March. The province did not say how many of the adults were pregnant.
Alberta is also offering an early and extra dose of the measles vaccine to babies as young as six months living in the harder hit south, central and north zones.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CTV News
2 hours ago
- CTV News
CTV National News: Speaking traditional language improves health in Indigenous community, study says
CTV National News: Speaking traditional language improves health in Indigenous community, study says Community members are passing on traditional Indigenous language and names to continue cultural connection. CTV News' Allison Bamford reports.


CTV News
5 hours ago
- CTV News
Vancouver now home to fastest PET/CT scanner in Canada
BC Cancer has rolled out a new diagnostic tool that it says is the fastest and most advanced of its kind in Canada. A new cancer screening machine that recently began operating at the BC Cancer Centre in Vancouver is the fastest and most advanced in Canada, according to officials. The Quadra PET/CT scanner is the first of its kind in the country, and it can capture a much larger picture than previous generations and is about 22 times more sensitive. 'It is the equivalent of four PET scanners put together, and essentially the area covers from the head to the pelvis,' said Dr. François Bénard, senior research director at BC Cancer and radiology professor at the University of B.C. 'We can image this entire area of the body in one shot, so you can do things that we could not do before.' In a nutshell, the new scanners give better quality images in less time and requires less radioactive drugs than previous machines, he told CTV News. A PET/CT scanner combines two imaging devices, positron emission technology, which looks at biochemistry, and computed tomography, which provides anatomical information. A PET scan requires an injection of a radioactive substance called a tracer, while a conventional CT scan does not. B.C. is home to three PET/CT machines, in Vancouver, Victoria and Kelowna. Notably, the new Quadra machine is the fastest of its kind, which means more scans can be performed and patients get a more comfortable experience. Bénard says it can take more time to position a patient in the machine than take the picture itself. 'When I started my career, it would take two hours to take a PET scan, now we can get a better PET/CT scan in less than 30 seconds,' he said. Bénard added that those getting a PET scan on an older machine need not worry—they are also very precise. 'If you're not getting a PET scan on that machine you should be reassured. BC Cancer has very modern instruments at other sites,' he said. What this new scanner will do right away is add capacity for more diagnostics and provide research opportunities in the radiopharmaceutical field at UBC, according to Bénard. In May, the BC Cancer Centre in Vancouver also got a state-of-the-art photon-counting CT scanner. With files from CTV News Vancouver's Spencer Harwood


CTV News
8 hours ago
- CTV News
New technology allows menstrual pads to screen for cervical cancer
(CT Murphy has been exploring the use of nanomaterials in menstrual pads to non-invasively detect human papillomavirus (HPV), a leading cause of cervical cancer. Image courtsey: CELLECT Laboratories Inc.) Innovative new technology could soon mean that screening for cervical cancer won't be as uncomfortable as a Pap test, according to two Waterloo, Ont., researchers. CELLECT Laboratories co-founders CT Murphy and Ibukun Elebute have been exploring the use of nanomaterials in menstrual pads to non-invasively detect human papillomavirus (HPV), a leading cause of cervical cancer. Murphy says her first experience with a Pap test prompted her to create this innovation as a final-year project studying nanotechnology at the University of Waterloo (uWaterloo). 'They are one of the most uncomfortable and archaic experiences I've ever had in the medical industry,' Murphy told in a phone interview. 'I was really taken aback with how little pain management there was.' Murphy later partnered with Elebute, a fellow uWaterloo alum with a background in biomedical and mechanical engineering, as well as business, to found CELLECT Laboratories Inc. Ibukun Elebute and CT Murphy. (Ibukun Elebute and CT Murphy. Image courtsey: CELLECT Laboratories Inc.) In the last two years, their nanomaterials research has won over $150,000 in funding at pitch competitions worldwide. 'I think it's been a very recent advent of people actually looking into women's health and realizing what a massive disparity there is,' Murphy said. 'Women are desperate for proper health care that is made for them, by them and that they can trust (…) this technology is not only wanted, but desperately needed.' 'It's clear that we are not building in isolation,' said Elebute. 'We're standing on the shoulders of a growing community that's pushing for real change in women's health, and that makes all the difference.' Cervical cancer screening in Canada Murphy says that modernization could help address low screening rates for cervical cancer – as it's one of the reasons contributing to what the Canadian Cancer Society calls the fastest increasing cancer in women. '(Women's) lives are at stake because of certain social stigmas surrounding one of the main diagnostic techniques for cervical cancer,' Murphy said. 'I think innovating in a way that makes (screening) more inviting and easier to use will mean a genuine improvement in not only quality of life, but the chances of survival for tons of women who are affected by HPV and cervical cancer every single day.' The incidence rate of cervical cancer has risen 3.7 per cent per year since 2015, the first significant increase since 1984 and a 'concerning' trend that a recent Canadian Medical Association Journal report notes is largely preventable. 'Not even optimally using technology' In Canada, several initiatives have already been introduced to address the rise in cervical cancer, including increased awareness of HPV vaccination and a shift to HPV testing rather than Pap or cytology tests. HPV testing requires less frequent screening and targets the high-risk types of HPV that lead to cervical cancer. Ontario, British Columbia, P.E.I. and Northwest Territories have all transitioned from Pap tests to HPV testing, and Quebec is offering the service in some regions, with plans to fully adopt it province-wide. B.C. is the first to offer at-home self-testing covered by the province, an option expected to be available in Ontario and New Brunswick in the future. All other provinces are in various stages of making the switch. Dr. Anna Wilkinson, a family physician and oncologist at The Ottawa Hospital, says the transition has been slow to come, nationally. Despite a decade data showing it to be more effective than cytology, federal screening guidelines recommend against HPV testing. Dr. Wilkinson says those guidelines are 12 years out of date. 'We're not even optimally using technology that's already proven and known,' she told 'Cervical cancer is almost entirely preventable, yet each year in Canada, many women die from it or undergo difficult treatments with lifelong side effects. We must modernize our national guidelines to include HPV vaccination, HPV cervical screening and self-screening, so that cervical cancer can be eradicated in Canada.' Current initiatives don't address all issues While Murphy and Elebute acknowledge the importance of recent modernization initiatives, they say the current self-testing model does not fully address the issues they aim to tackle. HPV testing kits may still trigger the same discomfort and stigma as Pap tests, Murphy notes, especially for survivors of sexual abuse, or those experiencing gender dysphoria. 'The swab simply does not alleviate the correct pain points,' she said. 'We are providing a noninvasive and familiar alternative that will incentivize those who do not seek out Pap smears to get tested for HPV.' That said, abnormal test results may still necessitate more invasive screening, such as a colposcopy or biopsy. 'Depending on what you have or what you want to look for, you might need to have one of those uncomfortable exams,' said Dr. Amanda Selk, an obstetrician gynecologist at Women's College Hospital in Toronto, in an interview. 'If you actually do have a high-risk HPV strain, then you have to have an exam with a speculum where we look at your cervix with a microscope to see if there's any pre-cancer happening there.' Coexisting in the current landscape With their prototype three years into testing and soon to move on to clinical trials, Murphy and Elebute say their intention is not to replace current models, but to coexist alongside existing lab workflows. 'Our goal is to enhance what's already available by making high-quality sample collection more accessible, comfortable and compatible with the realities of people's lives,' Elebute said. 'When we think about the future, we see CELLECT as a powerful complement to existing self-testing tools - expanding access, improving user experience and ultimately helping more people get screened earlier and more reliably.' In addition to screening for HPV and cervical cancer, Elebute says menstrual blood could be used as a diagnostic tool for other female reproductive conditions, transforming women's health care. 'We see different fluids used (in health care): blood, urine, stool; and you begin to wonder why the one thing that we're able to collect pretty much every month is not being used,' Elebute said. 'It's almost like a gold mine that we need to use to catch up on all the years we've fallen behind in women's health.'